Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.29 CNY | +0.87% |
|
+2.39% | -7.55% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.39x | 2.32x | 0.6x | 0.5x | 3.95x | 6.53x | 5.58% | 2.71B | |
| 15.48x | 1.37x | 1.91x | 0.59x | 9.28x | 9.97x | -.--% | 13.38B | |
| 19.09x | 2.33x | 0.33x | 0.91x | 14.13x | 14.44x | -.--% | 6.35B | |
| 15.25x | 1.59x | 1.75x | 0.68x | 7.03x | 8.87x | 2.45% | 5.62B | |
| 15.97x | 7.22x | 2.44x | 0.97x | 7.25x | 10.07x | 4.04% | 3.31B | |
| 14.51x | 4.38x | 13.83x | 1.23x | 7.47x | 14.49x | 5.7% | 3.24B | |
| 12.01x | 1.81x | 0.73x | 0.76x | 5.45x | 7.13x | 3.58% | 3.4B | |
| 41.1x | - | 1.31x | - | - | - | - | 2.67B | |
| 23.53x | 4.12x | 1.02x | 0.67x | 8.63x | 14.13x | 1.75% | 1.73B | |
| -92.11x | 3.03x | 1.55x | 0.48x | 17.89x | 108.15x | 0.01% | 1.6B | |
| 45.85x | 5.04x | 1.09x | 1.34x | 15.43x | 29.55x | - | 1.03B | |
| 11.93x | 2.4x | -4.26x | 0.87x | 7.12x | 13.43x | 5.55% | 995M | |
| 10.78x | 0.77x | 0.1x | 0.25x | 2.4x | 4.95x | 4.71% | 851M | |
| 27.42x | 7.39x | 1.13x | 0.98x | 13.45x | 21.33x | 1.33% | 803M | |
| 12.62x | 1.7x | 1.04x | 0.62x | 7.65x | 12.35x | 0.41% | 618M | |
| Average | 12.39x | 3.25x | 1.64x | 0.77x | 9.08x | 19.67x | 2.7% | 3.22B | |
| Weighted average by Cap. | 14.28x | 2.62x | 2.09x | 0.75x | 9.09x | 14.62x | 1.95% |
Select your edition
All financial news and data tailored to specific country editions
